#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Barth syndrome Extra-osseous Ewing's sarcoma recurrent Squamous cell carcinoma of the vulva Pituitary-dependent Cushing's syndrome Hypersensitivity pneumonitis Pouchitis Epilepsy with myoclonic-atonic seizures Mantle cell lymphoma stage II Erythema Squamous cell carcinoma of the cervix Turner's syndrome Neoplasm Burkitt's lymphoma Nodal marginal zone B-cell lymphoma Kaposi's sarcoma More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Treatment Retinoblastoma – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Erdheim-Chester disease – Trials in Disease Myelodysplastic syndrome with excess blasts – Diagnostics Breast angiosarcoma – Treatment IgA nephropathy – Life with Disease Mantle cell lymphoma stage II – Treatment MELAS syndrome – Basic Information Mantle cell lymphoma stage II – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Donanemab Dmd06-Mab COLESEVELAM HYDROCHLORIDE ATUMELNANT Octreotide 177Lu-Rhpsma-10.1 ULEFNERSEN TETRODOTOXIN SARACATINIB Vildagliptin Quizartinib Dihydrochloride Anselamimab 13N-AMMONIA Glasdegib PIPOTIAZINE Melatonin Piflufolastat (18F) ZIGAKIBART Romiplostim Vibegron More therapies…

    Learn about Your Condition

    Acquired haemophilia Rosai-Dorfman syndrome Subdural haematoma Lymphocyte adoptive therapy Amyotrophic lateral sclerosis Postoperative wound infection Breast cancer in situ Mitochondrial DNA depletion Pouchitis Lyme disease Weaning failure Breast cancer female Lymphocytic lymphoma Menopausal symptoms Oxygen saturation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Trastuzumab, Pertuzumab, and Tucatinib for Patients with Stage II-III HER2-Positive Breast Cancer Without Chemotherapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Tucatinib
    • Pertuzumab
    • Trastuzumab
    The Netherlands

  • Study on Pre-Surgery Immunotherapy with Relatlimab, Anti-IL-8 mAb, and Ipilimumab for Early-Stage Colon Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Anti-Il-8 Human Monoclonal Antibody
    • Celecoxib
    • Ipilimumab
    The Netherlands

  • Study on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal cancer index
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Topotecan
    • Bevacizumab
    • Dostarlimab
    Czechia France Germany Italy

  • Study of avelumab and cetuximab combination treatment after TPEx chemotherapy for patients with recurrent or metastatic head and neck cancer receiving first-line therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cetuximab
    France

  • Study on the Safety and Effectiveness of Repotrectinib for Patients with ROS1-Positive Non-Small Cell Lung Cancer and Active Brain Metastasis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Non-small cell lung cancer
    Investigated Drugs:
    • Repotrectinib
    Austria Germany Spain

  • Study on Human Plasma Protein vs. Crystalloid for Fluid Management in Children with Scoliosis Undergoing Spinal Fusion Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuromuscular scoliosis
    Investigated Drugs:
    • Human Plasma Protein
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    Finland
Previous Page
1 … 415 416 417 418 419 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!